San Antonio, TX, United States of America

Ming Qiu

This inventor holds 1 USPTO granted patent. Top assignee: Ctrc Research Foundation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Qiu. Retrieved from https://idiyas.com/inventor/ming-qiu-u13q3km2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ming Qiu

Introduction

Ming Qiu is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of cancer diagnostics through his innovative patent. His work focuses on improving the detection of telomerase activity, which is crucial for diagnosing various cancers.

Latest Patents

Ming Qiu holds a patent for "Rapid and sensitive assays for detecting and distinguishing between - Improved telomerase activity assays." This patent describes a method that utilizes a ligation sequential reaction (LSR) or BrdUTP to identify a telomerase-specific product. These assays are instrumental in diagnosing different types of cancers and assessing the clinical prospects for cancer patients. Furthermore, they can be employed to screen for substances that may interfere with telomerase activity.

Career Highlights

Ming Qiu is associated with the Ctrc Research Foundation, where he continues to advance his research and innovations. His work has the potential to significantly impact cancer diagnostics and treatment options.

Collaborations

Ming collaborates with esteemed colleagues, including Ira Maine and Bradford E Windle, who contribute to his research endeavors.

Conclusion

Ming Qiu's innovative work in cancer diagnostics through his patented assays showcases his dedication to improving healthcare outcomes. His contributions are vital in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…